Magazine | Aug. 28, 2015

How Plaquenil® May Help Prevent Heart Damage in Newborns

Under Investigation: Preventive care on the horizon

Video | Aug. 28, 2015

Biomarkers for Pediatric Lupus Nephritis (NpSLE)

Dr. Kathleen Sullivan of the Children's Hospital of Philadelphia provides an overview of here study on biomarkers for kidney disease in children and teens with lupus.

Blog | Aug. 03, 2015

Regulations for Off-Label Drugs Must Change

Off-label drugs for the treatment of lupus symptoms represents the standard of care for people with lupus, but current regulations make it difficult for doctors and manufacturers to communicate. Read Sandra C. Raymond's remarks now.

Research News | Aug. 03, 2015

New Study Highlights the Relationship between Adherence, ER Visits and Hospitalizations

Further studies may lead to interventions that improve the health outcomes of people with lupus.

General News | Jul. 28, 2015

Statement on the Results of Epratuzumab Study for the Treatment of Lupus

Results from a study of epratuzumab were released today. It did not meet its primary endpoint of clinically reducing the severity of lupus in people with mild to moderate disease. The following is a statement from Sandra C. Raymond, President and CEO

General News | Jun. 17, 2015

Lupus Foundation of America Hosts Capitol Conversation on 21st Century Cures Moderated by Chuck Todd

National Advocacy Awards Dinner recognizes leaders from Congress, federal agencies, industry and the research community.

General News | Jun. 10, 2015

Activists Urge Congress To Expand Critical Funding for Lupus Research

Lupus Foundation of America Hosts Awards Dinner & 21st Century Cures Discussion

Magazine | Apr. 08, 2015

Antiphospholipid Syndrome: Evaluating Current Treatment Options

Lupus is an autoimmune disease in which people generate antibodies against their own organs. But when antibodies to phospholipid-binding proteins are involved, a variety of complications can occur.